Pharmacists get training to better support cancer patients on oral medications
NCT ID NCT07677176
First seen Jun 30, 2026 · Last updated Jul 01, 2026 · Updated 1 time
Summary
This pilot study tests whether an educational program can help community pharmacists better support patients taking oral anticancer drugs. Thirty registered pharmacists in Malaysia will be randomly assigned to either attend the program or a control group. Researchers will measure how feasible and acceptable the program is, and gather early data on whether it improves pharmacists' knowledge and confidence.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Educational intervention on managing oral anticancer agents
What this could lead to
If successful, this program could better equip community pharmacists to support patients taking oral anticancer drugs, potentially improving patient care and safety.
What could go wrong
This is a small pilot study with only 30 participants in Malaysia, so results may not apply broadly. The intervention's impact on actual patient outcomes is not directly measured.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ORAL ANTI-TUMOR DRUGS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Monash University Malaysia
Subang Jaya, Selangor, Malaysia
Contact Phone: •••-•••-•••• Email: •••••@•••••